Denali Therapeutics Inc (DNLI)
Stock-Based Compensation
$69.95M
TTM · Period ending: · USD
DNLI Stock-Based Compensation
Latest reported$69.95Mperiod ending
Latest reported$69.95Mperiod ending
DNLI TTM Stock-Based Comp ($2.95M → $69.95M)
TTM stock-based compensation
High-resolution chart · PNG
DNLI stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 69,953,000 | |
| 47,038,000 | |
| 49,111,000 | |
| 50,238,000 | |
| 50,238,000 | |
| 75,338,000 | |
| 78,018,000 | |
| 78,928,000 | |
| 106,388,000 | |
| 81,288,000 | |
| 81,532,000 | |
| 55,544,000 | |
| 28,084,000 | |
| 28,084,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 13,252,000 | |
| 13,252,000 | |
| 24,037,000 | |
| 24,037,000 | |
| 19,686,000 | |
| 33,400,000 | |
| 29,489,000 | |
| 35,135,000 | |
| 31,744,000 | |
| 22,740,000 | |
| 18,791,000 | |
| 14,602,000 | |
| 10,220,000 | |
| 6,569,000 | |
| 4,409,000 | |
| 3,643,000 | |
| 3,675,000 | |
| 3,166,000 | |
| 2,951,000 |